Beren Therapeutics Secures $300M In Combined Financing With Hercules Capital To Support Investments In Commercial Readiness Activities For Adrabetadex Ahead Of November 17 PDUFA Target Action Date

뉴스 본문을 불러오고 있어요.

Beren Therapeutics Secures $300M In Combined Financing With Hercules Capital To Support Investments In Commercial Readiness Activities For Adrabetadex Ahead Of November 17 PDUFA Target Action Date | 웨이프 WAPE

Beren Therapeutics Secures $300M In Combined Financing With Hercules Capital To Support Investments In Commercial Readiness Activities For Adrabetadex Ahead Of November 17 PDUFA Target Action Date

기사 요약

관련 종목

댓글 —